Comprehensive Healthcare Systems, Inc.
CHS.V
TSX
| Weiss Ratings | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.53 | |||
| Price History | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 150.00% | |||
| 60-Day Total Return | 150.00% | |||
| 90-Day Total Return | 400.00% | |||
| Year to Date Total Return | 150.00% | |||
| 1-Year Total Return | 66.67% | |||
| 2-Year Total Return | -72.22% | |||
| 3-Year Total Return | -81.48% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -33.33% | |||
| 52-Week Low % Change | 300.00% | |||
| Price | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.03 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Apr 30, 2024 | |||
| 52-Week High Price (Date) | Mar 18, 2024 | |||
| Valuation | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.72M | |||
| Enterprise Value | 3.74M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -98.18% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.68 | |||
| Price/Book (Q) | -0.43 | |||
| Enterprise Value/Revenue (TTM) | 1.02 | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -5.75 | |||
| Enterprise Value/EBIT | -5.60 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 124.02M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | Suite 340 Edison, NJ 08817 | |||
| Website | comphealthcare.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -18.13% | |||
| Profit Margin | -3.40% | |||
| Management Effectiveness | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -40.97% | |||
| Return on Equity | -- | |||
| Income Statement | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.68M | |||
| Total Revenue (TTM) | 3.68M | |||
| Revenue Per Share | $0.03 | |||
| Gross Profit (TTM) | 1.59M | |||
| EBITDA (TTM) | -650.60K | |||
| EBIT (TTM) | -667.40K | |||
| Net Income (TTM) | -125.20K | |||
| Net Income Avl. to Common (TTM) | -125.20K | |||
| Total Revenue Growth (Q YOY) | 0.07% | |||
| Earnings Growth (Q YOY) | 140.56% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 140.66% | |||
| Balance Sheet | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 14.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 211.10K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -5.75M | |||
| Current Ratio (Q) | 0.039 | |||
| Book Value Per Share (Q) | -$0.05 | |||
| Total Assets (Q) | 597.90K | |||
| Total Current Liabilities (Q) | 5.45M | |||
| Total Debt (Q) | 2.17M | |||
| Total Liabilities (Q) | 6.35M | |||
| Total Common Equity (Q) | -5.75M | |||
| Cash Flow | CHS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -326.90K | |||
| Cash from Financing (TTM) | 216.50K | |||
| Net Change in Cash (TTM) | 2.10K | |||
| Levered Free Cash Flow (TTM) | -578.10K | |||
| Cash from Operations (TTM) | 112.50K | |||
